Clinical Trial Update: De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab Induction [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating a de novo everolimus-based regimen with rituximab induction for renal transplantation was terminated, with the trial no longer enroll…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• Afinitor (everolimus)
• Rituxan (rituximab)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Renal Insufficiency | Phase 4 | Status: TERMINATED